Bristol-Myers
Squibb Company (NYSE:BMY) will announce results for the fourth
quarter of 2017 on Monday, February 5, 2018. During a conference call at
8:00 a.m. ET on February 5th company executives will review financial
information and will address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast
of the call at http://investor.bms.com
or by dialing in the U.S. toll free 866-548-4713 or international
323-794-2093, confirmation code: 4392051. Materials related to the call
will be available at the same website prior to the conference call. A
replay of the call will be available beginning at 11:00 a.m. ET on
February 5, 2018 through 11:00 a.m. ET on February 19, 2018. The replay
will also be available through http://investor.bms.com
or by dialing in the U.S. toll free 888-203-1112 or international
719-457-0820 confirmation code: 4392051.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb Company Media: Ken Dominski, 609-252-5251 ken.dominski@bms.com orLisa McCormick Lavery, 609-252-7602 lisa.mccormicklavery@bms.com or Investors: John Elicker, 609-252-4611 john.elicker@bms.com orTim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com